CARDIZEM CD Drug Patent Profile
✉ Email this page to a colleague
When do Cardizem Cd patents expire, and what generic alternatives are available?
Cardizem Cd is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in CARDIZEM CD is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardizem Cd
A generic version of CARDIZEM CD was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
Summary for CARDIZEM CD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 10 |
Patent Applications: | 2,870 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CARDIZEM CD |
What excipients (inactive ingredients) are in CARDIZEM CD? | CARDIZEM CD excipients list |
DailyMed Link: | CARDIZEM CD at DailyMed |
Recent Clinical Trials for CARDIZEM CD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Early Phase 1 |
CAMC Health System | Phase 4 |
University of South Florida | N/A |
Pharmacology for CARDIZEM CD
Drug Class | Calcium Channel Blocker |
Mechanism of Action | Calcium Channel Antagonists Cytochrome P450 3A4 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for CARDIZEM CD
US Patents and Regulatory Information for CARDIZEM CD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | CARDIZEM CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020062-001 | Aug 10, 1992 | AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | CARDIZEM CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020062-004 | Dec 27, 1991 | AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | CARDIZEM CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020062-002 | Dec 27, 1991 | AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | CARDIZEM CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020062-003 | Dec 27, 1991 | AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | CARDIZEM CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020062-005 | Aug 24, 1999 | AB3 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDIZEM CD
International Patents for CARDIZEM CD
See the table below for patents covering CARDIZEM CD around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Taiwan | 265267 | ⤷ Try a Trial | |
South Korea | 970001656 | ⤷ Try a Trial | |
Ireland | 60929 | Controlled absorption diltiazem formulation | ⤷ Try a Trial |
Australia | 653223 | ⤷ Try a Trial | |
New Zealand | 226575 | CONTROLLED RELEASE FORMULATION CONTAINING CIS-(+)-3-ACETYLOXY-5-(2-(DIMETHYLAMINO)ETHYL)-2,3 DIHYDRO-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPINE-4(5H)ONE(DILTIAZEM) AND HAVING A SURROUNDING MEMBRANE | ⤷ Try a Trial |
Israel | 101896 | Diltiazem formulation | ⤷ Try a Trial |
Ireland | 56999 | PHARMACEUTICAL FORMULATION | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |